Panacea Biotec Limited

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange about a compliance under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the opening of a Special Window for Transfer and Dematerialization of physical shares.

Panacea Biotec Limited

Panacea Biotec Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended September 30, 2026.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during September 2026'. The company has provided data of shares dematerialized during the month of September 2026, with a total of 6,11,09,526 shares dematerialized.

Panacea Biotec Limited

Panacea Biotec Limited has submitted the Exchange a copy Scrutinizers report of Annual General Meeting held on September 29, 2026, and informed the Exchange regarding voting results.

Panacea Biotec Limited

Panacea Biotec Limited has held its 42nd Annual General Meeting on September 29, 2026, through video conferencing. The meeting was attended by several directors and officials, and the voting results will be submitted in due course. The company had provided remote e-voting facility to its members, which commenced on September 26, 2026, and ended on September 28, 2026.

Panacea Biotec Limited

Panacea Biotec Limited has received two Demand Orders from the Office of the Assistant Commissioner of Income Tax, Delhi, imposing a penalty of ~₹4.32 Crore on account of alleged misreporting/under reporting of income for Assessment Years 2022-23 and 2023-24.

Panacea Biotec Limited

Panacea Biotec Limited has received four Demand Orders from the Office of the Assistant Commissioner of Income Tax, Delhi, imposing a penalty of ~₹9.82 Crore on account of alleged misreporting/under reporting of income.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange about General Updates, specifically a reminder to physical shareholders to furnish PAN and KYC details for updation, and to dematerialize their shares with a Depository Participant.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication - Post dispatch of AGM Notice. The company has published a notice of its 42nd Annual General Meeting (AGM) in the Business Standard and Desh Sewak newspapers.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange about General Updates - Book closure for the purpose of AGM

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange about General Updates - Confirmation on letter being sent to the concerned shareholders providing the weblink for accessing the Annual Report for financial year 2025-26 and the Notice of the ensuing AGM, to be held on September 29, 2026, through Video Conferencing / Other Audio-Visual Means.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 29, 2026.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during August 2026'. The company has provided the data of shares dematerialized during the month of August 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange about a copy of newspaper publication regarding the 42nd Annual General Meeting of the Company scheduled to be held on September 29, 2026.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication regarding the approval of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.

Panacea Biotec Limited

Panacea Biotec Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 139 lakhs and a total income from operations of Rs. 13,471 lakhs.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange about a copy of newspaper publication regarding a special window for transfer and dematerialization of physical shares.

Panacea Biotec Limited

Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during July 2026'. The company has confirmed that no shares were dematerialized during the month of July 2026, with a total of 6,11,05,526 shares dematerialized as on July 31, 2026.

Panacea Biotec Limited

Panacea Biotec Limited has received a Letter of Award from UNICEF for the supply of bivalent Oral Polio Vaccine worth ~US$ 8.205 million in Calendar Year 2028.